These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1189 related articles for article (PubMed ID: 33180261)
1. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease. Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261 [TBL] [Abstract][Full Text] [Related]
2. Modelling neurodegenerative diseases with 3D brain organoids. Chang Y; Kim J; Park H; Choi H; Kim J Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450 [TBL] [Abstract][Full Text] [Related]
3. Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research. Bi FC; Yang XH; Cheng XY; Deng WB; Guo XL; Yang H; Wang Y; Li J; Yao Y Transl Neurodegener; 2021 Aug; 10(1):27. PubMed ID: 34372927 [TBL] [Abstract][Full Text] [Related]
4. Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting. Teli P; Kale V; Vaidya A Cell Tissue Res; 2023 Oct; 394(1):75-91. PubMed ID: 37572163 [TBL] [Abstract][Full Text] [Related]
5. Modeling Alzheimer's Disease Using Human Brain Organoids. Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268 [TBL] [Abstract][Full Text] [Related]
6. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age. Grenier K; Kao J; Diamandis P Mol Psychiatry; 2020 Feb; 25(2):254-274. PubMed ID: 31444473 [TBL] [Abstract][Full Text] [Related]
7. Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases. Lei T; Zhang X; Fu G; Luo S; Zhao Z; Deng S; Li C; Cui Z; Cao J; Chen P; Yang H Ageing Res Rev; 2024 Dec; 102():102517. PubMed ID: 39321879 [TBL] [Abstract][Full Text] [Related]
8. Modelling Alzheimer's disease using human brain organoids: current progress and challenges. Yanakiev M; Soper O; Berg DA; Kang E Expert Rev Mol Med; 2022 Dec; 25():e3. PubMed ID: 36517884 [TBL] [Abstract][Full Text] [Related]
9. Stem cell models of Alzheimer's disease: progress and challenges. Arber C; Lovejoy C; Wray S Alzheimers Res Ther; 2017 Jun; 9(1):42. PubMed ID: 28610595 [TBL] [Abstract][Full Text] [Related]
10. Central nervous system organoids for modeling neurodegenerative diseases. Hou PS; Kuo HC IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668 [TBL] [Abstract][Full Text] [Related]
11. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease. Wu YY; Chiu FL; Yeh CS; Kuo HC Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120 [TBL] [Abstract][Full Text] [Related]
12. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders. Lee CT; Bendriem RM; Wu WW; Shen RF J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354 [TBL] [Abstract][Full Text] [Related]
13. Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids. Sharma S; Gilberto VS; Rask J; Chatterjee A; Nagpal P ACS Chem Neurosci; 2024 Aug; 15(16):3009-3021. PubMed ID: 39084211 [TBL] [Abstract][Full Text] [Related]
14. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. Raja WK; Mungenast AE; Lin YT; Ko T; Abdurrob F; Seo J; Tsai LH PLoS One; 2016; 11(9):e0161969. PubMed ID: 27622770 [TBL] [Abstract][Full Text] [Related]
15. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders. Fan W; Sun Y; Shi Z; Wang H; Deng J Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155 [TBL] [Abstract][Full Text] [Related]
16. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure. Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898 [TBL] [Abstract][Full Text] [Related]
17. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling. Eglen RM; Reisine T SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678 [TBL] [Abstract][Full Text] [Related]
18. Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms. Sreenivasamurthy S; Laul M; Zhao N; Kim T; Zhu D Bioeng Transl Med; 2023 Mar; 8(2):e10378. PubMed ID: 36925717 [TBL] [Abstract][Full Text] [Related]
19. 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling. Centeno EGZ; Cimarosti H; Bithell A Mol Neurodegener; 2018 May; 13(1):27. PubMed ID: 29788997 [TBL] [Abstract][Full Text] [Related]
20. Unlocking Neural Function with 3D In Vitro Models: A Technical Review of Self-Assembled, Guided, and Bioprinted Brain Organoids and Their Applications in the Study of Neurodevelopmental and Neurodegenerative Disorders. D'Antoni C; Mautone L; Sanchini C; Tondo L; Grassmann G; Cidonio G; Bezzi P; Cordella F; Di Angelantonio S Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]